Position in ROIV
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$3,539
-$616 QoQ
Shares Held
100
-33.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#445
of 494 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TOTH FINANCIAL ADVISORY CORP holds $11,360,807 across 23 Biotechnology names. ROIV ranks #15 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
15,760 | $1,786,553 | |
| 2 | KRYS |
Krystal Biotech, Inc.
|
4,511 | $1,676,603 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
6,600 | $1,590,402 | |
| 4 | ASND |
Ascendis Pharma A/S
|
5,880 | $1,568,313 | |
| 5 | ARGX |
Argenx SE
|
1,323 | $1,227,439 | |
| 6 | MIRM |
Mirum Pharmaceuticals, Inc.
|
10,285 | $1,204,064 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,000 | $1,073,900 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
7,800 | $866,034 |
All Filings in ROIV
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,539 | 100 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $4,155 | 150 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $3,255 | 150 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $2,269 | 150 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $1,690 | 150 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $1,513 | 150 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $1,774 | 150 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $3,115 | 270 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $1,585 | 150 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $1,581 | 150 | Shares | Sole | 2024-04-16 | |
| No filing history on record for this holder in this stock. | ||||||